ELOX logo

Eloxx Pharmaceuticals (ELOX) Company Overview

Profile

Full Name:

Eloxx Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 26, 1999

Indexes:

Not included

Description:

Eloxx Pharmaceuticals focuses on developing innovative treatments for genetic diseases caused by nonsense mutations. Their main goal is to improve the lives of patients with rare conditions by using advanced therapies that target the underlying genetic issues, aiming for effective and safe solutions.

Events Calendar

Earnings

Next earnings date:

Feb 17, 2025

Recent quarterly earnings:

Nov 13, 2023

Recent annual earnings:

Apr 3, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 2, 2022

Analyst ratings

Recent major analysts updates

Jul 11, 23 Oppenheimer
Outperform
Apr 6, 23 Oppenheimer
Outperform
May 23, 22 Piper Sandler
Overweight
May 9, 22 HC Wainwright & Co.
Neutral
Dec 17, 21 Oppenheimer
Outperform
Nov 18, 21 HC Wainwright & Co.
Neutral
Nov 11, 21 HC Wainwright & Co.
Neutral
Jun 30, 21 Mizuho
Buy
May 27, 21 B. Riley Securities
Buy
Jun 11, 20 Citigroup
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
ELOX
globenewswire.comJuly 11, 2024

First two subjects dosed in Phase 1 clinical trial of ZKN-013; ZKN-013 is being developed for the potential treatment of rare dermatological and other diseases associated with nonsense mutations

Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor
Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor
Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor
ELOX
InvestorPlaceDecember 5, 2023

While getting kicked off an exchange typically signals about the biggest warning sign you can possibly receive, a (somewhat) rational argument exists for delisted stocks to buy. Psychologically, companies go through much anxiety doing whatever they can to stay listed in a major exchange.

This Small Cap Stock Surged Over 100%
This Small Cap Stock Surged Over 100%
This Small Cap Stock Surged Over 100%
ELOX
MarketBeatJuly 12, 2023

Arguably the most impressive mover yesterday was a stock you have probably never heard of. Shares of Eloxx Pharmaceuticals NASDAQ: ELOX rocketed almost 100% yesterday after receiving an increased price target from Oppenheimer.

Why Is Eloxx Pharmaceuticals (ELOX) Stock Down 27% Today?
Why Is Eloxx Pharmaceuticals (ELOX) Stock Down 27% Today?
Why Is Eloxx Pharmaceuticals (ELOX) Stock Down 27% Today?
ELOX
InvestorPlaceMay 16, 2023

Eloxx Pharmaceuticals (NASDAQ: ELOX ) stock is falling hard on Tuesday after the company provided a weak earnings report for Q1 2023. The bad news for ELOX stock starts with its losses per share of $2.88 cents.

Senesco Technologies Inc. (ELOX) Reports Q1 Loss, Lags Revenue Estimates
Senesco Technologies Inc. (ELOX) Reports Q1 Loss, Lags Revenue Estimates
Senesco Technologies Inc. (ELOX) Reports Q1 Loss, Lags Revenue Estimates
ELOX
Zacks Investment ResearchMay 15, 2023

Senesco Technologies Inc. (ELOX) came out with a quarterly loss of $2.88 per share versus the Zacks Consensus Estimate of a loss of $2.55. This compares to loss of $5.20 per share a year ago.

FAQ

  • What is the ticker symbol for Eloxx Pharmaceuticals?
  • Does Eloxx Pharmaceuticals pay dividends?
  • What sector is Eloxx Pharmaceuticals in?
  • What industry is Eloxx Pharmaceuticals in?
  • What country is Eloxx Pharmaceuticals based in?
  • When did Eloxx Pharmaceuticals go public?
  • Is Eloxx Pharmaceuticals in the S&P 500?
  • Is Eloxx Pharmaceuticals in the NASDAQ 100?
  • Is Eloxx Pharmaceuticals in the Dow Jones?
  • When was Eloxx Pharmaceuticals's last earnings report?
  • When does Eloxx Pharmaceuticals report earnings?
  • Should I buy Eloxx Pharmaceuticals stock now?

What is the ticker symbol for Eloxx Pharmaceuticals?

The ticker symbol for Eloxx Pharmaceuticals is NASDAQ:ELOX

Does Eloxx Pharmaceuticals pay dividends?

No, Eloxx Pharmaceuticals does not pay dividends

What sector is Eloxx Pharmaceuticals in?

Eloxx Pharmaceuticals is in the Healthcare sector

What industry is Eloxx Pharmaceuticals in?

Eloxx Pharmaceuticals is in the Biotechnology industry

What country is Eloxx Pharmaceuticals based in?

Eloxx Pharmaceuticals is headquartered in United States

When did Eloxx Pharmaceuticals go public?

Eloxx Pharmaceuticals's initial public offering (IPO) was on April 26, 1999

Is Eloxx Pharmaceuticals in the S&P 500?

No, Eloxx Pharmaceuticals is not included in the S&P 500 index

Is Eloxx Pharmaceuticals in the NASDAQ 100?

No, Eloxx Pharmaceuticals is not included in the NASDAQ 100 index

Is Eloxx Pharmaceuticals in the Dow Jones?

No, Eloxx Pharmaceuticals is not included in the Dow Jones index

When was Eloxx Pharmaceuticals's last earnings report?

Eloxx Pharmaceuticals's most recent earnings report was on Nov 13, 2023

When does Eloxx Pharmaceuticals report earnings?

The next expected earnings date for Eloxx Pharmaceuticals is Feb 17, 2025

Should I buy Eloxx Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions